1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

New Biocalysis Technology

Have updates for this profile?  Please contribute data

About
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2015

Location

Wuhan Hubei China

Primary Industry

Biotechnology

About

Established in 2015 and based in Wuhan, China, New Biocalysis Technology is a company focusing on the research and development, production, and technology of raw materials for bio-pharmaceutical and IVD industry. The company has developed more than 100 raw materials of IVD reagents, its IVD products are used in bio-pharmaceutical, vaccine production, molecular diagnosis, and bio-sensing etc. The company is in partnership with over 100 IVD reagent manufacturers, and selling the products to 25 countries.
Current Investors
Hanhai International, Sanze Venture Capital Management, Wuhan Optics Valley Elite Investment Management

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.hzymes.com
Company Stage
Series C
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo